As Japan’s working population declines, the country faces mounting pressure to manage healthcare costs and improve patient outcomes. Companies across the medical landscape are investing in artificial intelligence, digital platforms and pharmaceutical innovation to transform the nation’s healthcare system. Japan’s evolving approach — from high-tech diagnostics and preventive care to global partnerships and medical tourism — reveals how demographic challenges are driving new strategies with international relevance.
All interviews were conducted by The Worldfolio and can be found at http://www.theworldfolio.com.
This news is powered by Newsweek 
